<

NANOBIOTIX (EPA:NANO) Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation

Transparency directive : regulatory news

02/04/2024 22:15



Other stories

20/04/2024 13:34
20/04/2024 14:00
20/04/2024 15:31
20/04/2024 16:37
19/04/2024 20:46
20/04/2024 14:32
20/04/2024 12:15
20/04/2024 16:58
20/04/2024 18:20
20/04/2024 13:27
20/04/2024 09:19
20/04/2024 11:25
20/04/2024 13:26
19/04/2024 14:08
20/04/2024 14:03
20/04/2024 13:57
19/04/2024 19:17
19/04/2024 01:56
19/04/2024 15:16
20/04/2024 05:35
19/04/2024 18:00
19/04/2024 12:17
20/04/2024 10:27
20/04/2024 07:00
20/04/2024 16:12
20/04/2024 11:09
20/04/2024 18:03
20/04/2024 15:54
20/04/2024 17:32
20/04/2024 15:40
20/04/2024 10:29
20/04/2024 09:37
19/04/2024 21:18
20/04/2024 12:37
19/04/2024 23:53
20/04/2024 10:53
20/04/2024 08:56
20/04/2024 09:53